Tsur2019 - Response of patients with melanoma to immune checkpoint blockade
Ontology highlight
ABSTRACT:
This is a simple mathematical population model for pembrolizumab-treated advanced melanoma patients, used to predict the response of melanoma patients to immune checkpoint inhibitors.
SUBMITTER:
Johannes Meyer
PROVIDER: BIOMD0000000838 | BioModels | 2024-09-02
REPOSITORIES: BioModels
ACCESS DATA